<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00196885</url>
  </required_header>
  <id_info>
    <org_study_id>whilde157/2003</org_study_id>
    <nct_id>NCT00196885</nct_id>
  </id_info>
  <brief_title>Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training</brief_title>
  <official_title>Effect of N-Acetylcysteine on Skeletal Muscle in Cachectic Cancer Patients Undergoing a Resistance Training Program (Phase 2 Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Cancer Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Cancer Research Center</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to tests the hypothesis, that N-acetylcysteine (a
      thiol-antioxidant)improves the exercise training effect on cancer patients that experience
      weight loss (cachexia) as assessed by muscle mass and function as well as histomorphology.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2003</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>muscle cross-sectional area, peak forces</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>muscle fiber composition (biopsy vastus lateralis muscle mRNA levels of cytokines, myostatin. Activity of Akt-dependent pathways</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle 31Phospho-magnetic-resonance spectroscopy</measure>
  </secondary_outcome>
  <enrollment>60</enrollment>
  <condition>Gastrointestinal Neoplasms</condition>
  <condition>Bronchial Carcinoma</condition>
  <condition>Hodgkin Disease</condition>
  <condition>Non-Hodgkin Lymphoma</condition>
  <condition>Weight Loss</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>N-acetylcysteine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  gastrointestinal or bronchial cancer

          -  weight loss of 10% within 6 months

          -  sufficient mobility

        Exclusion Criteria:

          -  severe pain, steroid therapy, severe internal, muscular, neurological, psychiatric
             disease, N-acetylcysteine allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wulf Hildebrandt, MD</last_name>
    <role>Study Director</role>
    <affiliation>German Cancer Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>German Cancer Research Center, D020</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Hauer K, Hildebrandt W, Sehl Y, Edler L, Oster P, Dröge W. Improvement in muscular performance and decrease in tumor necrosis factor level in old age after antioxidant treatment. J Mol Med (Berl). 2003 Feb;81(2):118-25. Epub 2003 Feb 8.</citation>
    <PMID>12601528</PMID>
  </reference>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>June 18, 2008</last_update_submitted>
  <last_update_submitted_qc>June 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2008</last_update_posted>
  <keyword>cancer cachexia</keyword>
  <keyword>muscle wasting</keyword>
  <keyword>weight loss</keyword>
  <keyword>proteolysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
    <mesh_term>Hodgkin Disease</mesh_term>
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
    <mesh_term>Digestive System Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Bronchogenic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetylcysteine</mesh_term>
    <mesh_term>N-monoacetylcystine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

